Phase II treatment of adults with newly diagnosed, progressive or recurrent primary malignant anaplastic oligodendroglioma with Temodal
Phase of Trial: Phase II
Latest Information Update: 20 Oct 2009
At a glance
- Drugs Temozolomide (Primary)
- Indications Glioma
- Focus Therapeutic Use
- 20 Oct 2009 Actual end date (Feb 2001) added as reported by ClinicalTrials.gov.
- 20 Oct 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Sep 2005 New trial record.